Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Recruiting 2Completed 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Heart Failure 1Cardiovascular Diseases 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Angiotensin-Converting Enzyme Inhibitors × Clear all
NCT03127631 2025-01-31

RADICALPC

McMaster University

Phase NA Recruiting
6,000 enrolled
Genitourinary

Cardiovascular Diseases, Prostatic Neoplasms

NCT02818517 2022-02-02

Evaluation and Management of Cardio Toxicity in Oncologic Patients

Tel-Aviv Sourasky Medical Center

Recruiting
1,000 enrolled

Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡